TWI640542B - 血管加壓素-2受器促效劑 - Google Patents

血管加壓素-2受器促效劑 Download PDF

Info

Publication number
TWI640542B
TWI640542B TW103125533A TW103125533A TWI640542B TW I640542 B TWI640542 B TW I640542B TW 103125533 A TW103125533 A TW 103125533A TW 103125533 A TW103125533 A TW 103125533A TW I640542 B TWI640542 B TW I640542B
Authority
TW
Taiwan
Prior art keywords
compound
peptide
alkyl
dmf
mmol
Prior art date
Application number
TW103125533A
Other languages
English (en)
Chinese (zh)
Other versions
TW201536815A (zh
Inventor
凱茲梅茲 衛斯鈕斯奇
克勞迪歐 史坦蓋特
皮爾 瑞維爾
Original Assignee
菲瑞茵公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 菲瑞茵公司 filed Critical 菲瑞茵公司
Publication of TW201536815A publication Critical patent/TW201536815A/zh
Application granted granted Critical
Publication of TWI640542B publication Critical patent/TWI640542B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
TW103125533A 2013-07-26 2014-07-25 血管加壓素-2受器促效劑 TWI640542B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361859024P 2013-07-26 2013-07-26
US61/859,024 2013-07-26
US201461952073P 2014-03-12 2014-03-12
US61/952,073 2014-03-12

Publications (2)

Publication Number Publication Date
TW201536815A TW201536815A (zh) 2015-10-01
TWI640542B true TWI640542B (zh) 2018-11-11

Family

ID=51398870

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103125533A TWI640542B (zh) 2013-07-26 2014-07-25 血管加壓素-2受器促效劑

Country Status (27)

Country Link
US (2) US10131692B2 (https=)
EP (1) EP3024829B1 (https=)
JP (1) JP6387095B2 (https=)
KR (1) KR102198130B1 (https=)
CN (1) CN105492441B (https=)
AU (1) AU2014292860B2 (https=)
BR (1) BR112016000436B1 (https=)
CA (1) CA2919208A1 (https=)
DK (1) DK3024829T3 (https=)
EA (1) EA029392B1 (https=)
ES (1) ES2656039T3 (https=)
HR (1) HRP20180009T1 (https=)
HU (1) HUE035252T2 (https=)
IL (1) IL243730B (https=)
JO (1) JO3371B1 (https=)
LT (1) LT3024829T (https=)
MX (1) MX363355B (https=)
MY (1) MY183429A (https=)
PH (1) PH12016500044A1 (https=)
PL (1) PL3024829T3 (https=)
PT (1) PT3024829T (https=)
RS (1) RS56604B1 (https=)
SG (1) SG11201600031RA (https=)
SI (1) SI3024829T1 (https=)
TW (1) TWI640542B (https=)
WO (1) WO2015013690A1 (https=)
ZA (1) ZA201600145B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102176900B (zh) 2008-09-17 2017-09-26 克艾思马有限公司 药物组合物和相关的给药方法
CA3037581A1 (en) 2016-10-21 2018-04-26 Chiasma, Inc. Terlipressin compositions and their methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001373A1 (en) * 1993-06-29 1995-01-12 Ferring B.V. Process for manufacture of 1-deamino-8-d-arginine vasopressin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE399252B (sv) * 1976-05-24 1978-02-06 Ferring Ab Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin
CA1246055A (en) * 1980-03-24 1988-12-06 Joseph H. Cort N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs
DK153883A (da) 1982-04-20 1983-10-21 Ceskoslovenska Akademie Ved Vasopressin-analoge
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
CZ292131B6 (cs) 2000-02-16 2003-08-13 Ústav organické chemie a biochemie AV ČR Synthetické analogy Desmopressinu chráněné v C-terminální sekvenci proti karboxyamidasovému štěpení
JP6131120B2 (ja) * 2013-06-19 2017-05-17 株式会社パイオラックス コネクタ

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001373A1 (en) * 1993-06-29 1995-01-12 Ferring B.V. Process for manufacture of 1-deamino-8-d-arginine vasopressin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Manning, Maurice, et al. "C-Terminal deletions in antagonistic analogs of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors." Journal of medicinal chemistry 30.12 (1987): 2245-2252. *

Also Published As

Publication number Publication date
US10745443B2 (en) 2020-08-18
EP3024829B1 (en) 2017-11-08
PH12016500044B1 (en) 2016-03-28
JP2016527255A (ja) 2016-09-08
JP6387095B2 (ja) 2018-09-05
HK1218647A1 (en) 2017-03-03
DK3024829T3 (en) 2017-12-04
ES2656039T3 (es) 2018-02-22
PT3024829T (pt) 2017-12-18
MY183429A (en) 2021-02-18
IL243730B (en) 2019-09-26
AU2014292860A1 (en) 2016-01-28
EA029392B1 (ru) 2018-03-30
MX2016000525A (es) 2016-04-07
HRP20180009T1 (hr) 2018-02-09
CN105492441B (zh) 2019-09-10
HUE035252T2 (en) 2018-05-02
US20150307555A1 (en) 2015-10-29
EA201690219A1 (ru) 2016-11-30
TW201536815A (zh) 2015-10-01
US20190194257A1 (en) 2019-06-27
NZ716342A (en) 2021-03-26
SI3024829T1 (en) 2018-01-31
US10131692B2 (en) 2018-11-20
RS56604B1 (sr) 2018-02-28
PH12016500044A1 (en) 2016-03-28
MX363355B (es) 2019-03-21
PL3024829T3 (pl) 2018-04-30
IL243730A0 (en) 2016-04-21
WO2015013690A1 (en) 2015-01-29
KR102198130B1 (ko) 2021-01-05
AU2014292860B2 (en) 2017-10-05
BR112016000436A2 (https=) 2017-07-25
LT3024829T (lt) 2017-12-27
JO3371B1 (ar) 2019-03-13
CA2919208A1 (en) 2015-01-29
SG11201600031RA (en) 2016-02-26
CN105492441A (zh) 2016-04-13
ZA201600145B (en) 2020-01-29
BR112016000436B1 (pt) 2022-07-05
KR20160034943A (ko) 2016-03-30
EP3024829A1 (en) 2016-06-01

Similar Documents

Publication Publication Date Title
RU2450017C2 (ru) Лиганды меланокортиновых рецепторов, модифицированные гидантоином
SK13082001A3 (sk) Cyklický peptidový analóg a jeho výroba
TWI640542B (zh) 血管加壓素-2受器促效劑
TW201630929A (zh) 降鈣素基因相關胜肽(cgrp)拮抗劑胜肽
US20120129774A1 (en) Kinin b1 receptor peptide agonists and uses thereof
HK1218647B (en) Vasopressin-2 receptor agonists
EP3464324B1 (en) Angiotensin-1-receptor antagonists
TWI776812B (zh) 血管收縮素-1-受體拮抗劑
NZ716342B2 (en) Vasopressin-2 receptor agonists
HK40004701A (en) Angiotensin-1-receptor antagonists
HK40004701B (en) Angiotensin-1-receptor antagonists
EA041581B1 (ru) Антагонисты рецептора ангиотензина-1

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees